Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 21, 2025
Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan.
Journal: JCO precision oncology
Published: May 29, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.
Journal: Cancer discovery
Published: April 15, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.
Journal: bioRxiv : the preprint server for biology
Published: May 20, 2024
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer.
Journal: NPJ breast cancer
Published: April 08, 2024
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer.
Journal: NPJ precision oncology
Published: January 31, 2024
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.
Journal: Clinical breast cancer
Published: April 10, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026